$MC

Analysts made several rating changes: UBS upgraded Invesco (IVZ) to Buy with a $41 target, Raymond James initiated M&T Bank (MTB) as Outperform with a $250 target, Morgan Stanley upgraded Nexa Resources (NEXA) to Overweight, and others. KeyBanc upgraded Corteva (CTVA) to Overweight with a $17 target, Jefferies upgraded Ambiq Micro (AMBQ) to Buy with a $90 target, and Citi upgraded Flutter to Buy with a $91 target.

UBS upgraded Moelis & Company (MC) to Neutral from Sell, lowering its price target to $59. The bank cited a reset in stock valuation and a challenging M&A backdrop, particularly in sponsor activity. Moelis's Q2 2026 earnings beat expectations, with $0.63 EPS on $409.4M revenue, a 12% year-over-year increase. The company faces challenges related to Saudi Arabia's regional headquarters requirements.

Shropshire Kenneth sold 1,881 shares of Moelis & Co (MC) at $69.06 ($0.13M total) on 2026-08-27.

Perella Weinberg (PJT) reported flat revenue of $156.5M, beating EPS estimates, with stock up 7.1%. Houlihan Lokey (HLI) saw revenue drop 15.6% to $511M, missing estimates, with stock down 8%. Goldman Sachs (GS) reported $20.34B revenue, up 39.5%, beating estimates, but stock down 4%. Moelis (MC) reported $409.4M revenue, up 12%, beating estimates, with stock up 2.5%.

A Q2 recap of 15 investment banking and brokerage stocks says the group’s revenues beat analysts’ consensus by 4.5%, while next-quarter guidance was 1.1% below. Raymond James (RJF) reported $3.93B revenue (+15.6% YoY), beating by 1.4%. Houlihan Lokey (HLI) reported $511M revenue (-15.6%), missing by 16.3%.

WATANABE OSAMU R. (General Counsel, Secretary) sold 4,850 shares of Moelis & Co (MC) at $69.30 ($0.34M total) on 2026-08-04.

Moelis & Company (NYSE: MC) reported Q2 CY2026 results. Revenue rose 12% year on year to $409.4 million, exceeding Wall Street estimates by 5.6%, according to the company. Non-GAAP profit was $0.63 per share, 3.2% above analysts’ consensus, also per the company.

Moelis & Co (MC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share • Record second quarter revenues of $409.4 million, up 12% from the prior year period • Record first half revenues of $729.2 million,

After strong Q2 earnings at major banks driven by higher investment banking and trading revenues, Moelis and Lazard shares rose in the afternoon. The article cites a “booming” dealmaking environment and notes Lazard’s stock jumped 5% and was tied to a Warburg Pincus mandate involving Oxylabs. Lazard is $43.37, down 12.8% YTD.

Moelis & Co (MC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K Moelis & Co false 0001596967 0001596967 2026-06-25 2026-06-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported